Progression into sepsis: An individualized process varying by the interaction of comorbidities with the underlying infection
Ημερομηνία
2018Γλώσσα
en
Λέξη-κλειδί
Επιτομή
Background: Development of sepsis is a process with significant variation among individuals. The precise elements of this variation need to be defined. This study was designed to define the way in which comorbidities contribute to sepsis development. Methods: Three thousand five hundred nine patients with acute pyelonephritis (AP), community-acquired pneumonia (CAP), intraabdominal infections (IAI) or primary bacteremia (BSI) and at least two signs of the systemic inflammatory response syndrome were analyzed. The study primary endpoint was to define how comorbidities as expressed in the Charlson's comorbidity index (CCI) and the underlying type of infection contribute to development of organ dysfunction. The precise comorbidities that mediate sepsis development and risk for death among 18 comorbidities recorded were the secondary study endpoints. Results: CCI more than 2 had an odds ratio of 5.67 for sepsis progression in patients with IAI between significantly higher than AP and BSI. Forward logistic regression analysis indicated seven comorbidities that determine transition into sepsis in patients with AP, four comorbidities in CAP, six comorbidities in IAI and one in BSI. The odds ratio both for progression to sepsis and death with one comorbidity or with two and more comorbidities was greater than in the absence of comorbidities. Conclusions: The study described how different kinds of infection vary in the degree to which they lead to sepsis. The number of comorbidities that enhances the risk of sepsis and death varies depending on the underlying infections. © 2018 The Author(s).
Collections
Related items
Showing items related by title, author, creator and subject.
-
Incidence, risk factors and validation of the RABBIT score for serious infections in a cohort of 1557 patients with rheumatoid arthritis
Thomas K., Lazarini A., Kaltsonoudis E., Voulgari P.V., Drosos A.A., Repa A., Sali A.M.I., Sidiropoulos P., Tsatsani P., Gazi S., Evangelia A., Boki K.A., Katsimbri P., Boumpas D., Fragkiadaki K., Tektonidou M.G., Sfikakis P.P., Karagianni K., Sakkas L.I., Grika E.P., Vlachoyiannopoulos P.G., Evangelatos G., Iliopoulos A., Dimitroulas T., Garyfallos A., Melissaropoulos K., Georgiou P., Areti M., Georganas C., Vounotrypidis P., Georgiopoulos G., Kitas G.D., Vassilopoulos D. (2021)Objectives: Predicting serious infections (SI) in patients with rheumatoid arthritis (RA) is crucial for the implementation of appropriate preventive measures. Here we aimed to identify risk factors for SI and to validate ... -
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae
Gutiérrez-Gutiérrez B., Salamanca E., de Cueto M., Pascual A., Rodríguez-Baño J., Hsueh P.-R., Viale P., Paño-Pardo J.R., Venditti M., Tumbarello M., Daikos G., Pintado V., Doi Y., Tuon F.F., Karaiskos I., Machuca I., Schwaber M.J., Azap Ö.K., Souli M., Roilides E., Pournaras S., Akova M., Pérez F., Bonomo R.A., Bermejo J., Oliver A., Almela M., Lowman W., Almirante B., Carmeli Y., Paterson D.L., Falcone M., Russo A., Giamarellou H., Trecarichi E.M., Losito A.R., García-Vázquez E., Hernández A., Gómez J., Iosifidis E., Prim N., Navarro F., Mirelis B., Origüen J., San Juan R., Fernández-Ruiz M., Larrosa N., Puig-Asensio M., Cisneros J.M., Molina J., González V., Rucci V., Ruiz de Gopegui E., Marinescu C.I., Martínez-Martínez L., Fariñas M.C., Cano M.E., Gozalo M., Mora-Rillo M., Navarro-San Francisco C., Peña C., Gómez-Zorrilla S., Tubau F., Tsakris A., Zarkotou O., Pitout J., Virmani D., Torre-Cisneros J., Natera C., Helvaci Ö., Sahin A.O., Cantón R., Ruiz P., Bartoletti M., Giannella M., Taconelli E., Riemenschneider F., Calbo E., Badia C., Xercavins M., Gasch E., Fontanals D., Jové E. (2016)Objective To develop a score to predict mortality in patients with bloodstream infections (BSIs) due to carbapenemase-producing Enterobacteriaceae (CPE). Patients and Methods A multinational retrospective cohort study ... -
Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: Experience from a national registry study
Karaiskos I., ikaraiskos@hygeia.gr, Daikos G.L., Gkoufa A., Adamis G., Stefos A., Symbardi S., Chrysos G., Filiou E., Basoulis D., Mouloudi E., Galani L., Akinosoglou K., Arvaniti K., Masgala A., Petraki M., Papadimitriou E., Galani I., Poulakou G., Routsi C., Giamarellou H. (2021)Background: Infections caused by KPC-producing Klebsiella pneumoniae (Kp) are associated with high mortality. Therefore, new treatment options are urgently required. Objectives: To assess the outcomes and predictors of ...